Feasibility and Safety of Bile Duct Clearance by Transcystic Sphincter of Oddi Balloon Dilatation

Surgery Clinical Trial

— TCPBD  

Official title:

Feasibility and Safety of Intraoperative Bile Duct Clearance by Sphincter of Oddi Balloon Dilatation: A Prospective Observational Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04737642
• Other study ID #: BASEC 2020-01066
• Status: Completed
• Phase: N/A
• Start date: January 4, 2021
• Est. completion date: October 9, 2022

Study information

• Verified date: January 2023
• Source: University Hospital Inselspital, Berne
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate feasibility and safety of intraoperative bile duct clearance by sphincter of Oddi balloon dilatation via cystic duct at cholecystectomy. Primary endpoint: rate of successful bile duct stone clearance (feasibility). Secondary endpoints (safety): rate of peri-interventional complications (injury to the common bile duct, bleeding, injury to surrounding organs: stomach, duodenum, liver) and short-term postoperative complications (bile leak, cholangitis, lipasaemia, pancreatitis, pneumonia). Duration of procedure. Length of hospital stay.

Description:

Standard approach to address common bile duct stones is endoscopic retrograde cholangiography (ERC) with sphincterotomy. Those interventions are performed either before or after gallbladder removal (cholecystectomy), thus, requiring at least two interventions. Moreover, ERC with sphincterotomy is associated with a considerable rate of short and long-term morbidity. The main complications are pancreatitis (2-7%), post sphincterotomy bleeding (1-2%), impaired function of the sphincter with reflux of duodenal content to the bile ducts and a consecutive risk for cholangitis, stone recurrence and even a potential higher risk for cholangiocarcinoma. The aim of this study is to evaluate an alternative surgical approach of bile duct clearance at the time of cholecystectomy. Literature of this approach is scarce; however, it has shown a trend to lower postoperative complications if compared to ERC. The technique of sphincter of Oddi balloon dilatation and bile duct clearance from stones via cystic duct at cholecystectomy has been described in a few case series. These small case series have shown a good success rate of bile stone clearance and low complication rates when applying the balloon dilation technique for smaller stones. The investigators have used this technique in selected cases with good success as well. However, the technique needs to be assessed regarding feasibility and safety in a consecutive group of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: October 9, 2022
• Est. primary completion date: July 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Informed Consent as documented by signature (Appendix Informed Consent Form)
• Patients = 18 years of age
• Patients with gallbladder stones and known or expected concomitant bile duct stones
• Bile duct stones = 6mm in size measured by intraoperative cholangiography

Exclusion Criteria:

• Women who are pregnant
• Declined consent
• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
• Enrolment of the investigator, his/her family members, employees and other dependent persons
• Patients with moderate or severe acute cholangitis
• Patients with moderate or severe pancreatitis

Related Conditions & MeSH terms

• Cholecystolithiasis
• Choledocholithiasis
• Cholelithiasis
• Gallstones
• Surgery

Intervention

Procedure:
• Papillary ballon dilatation
Trans cystic papillary ballon dilatation during cholecystectomy

Locations

Country	Name	City	State
Switzerland	Inselspital Bern (Department for Visceral Surgery and Medicine)	Bern

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of successful bile duct stone clearance (feasibility)	Intraoperative cholangiogram showing no persistent stones in the common bile duct after the study procedure	During operation, up to 2 hours
Primary	Rate of successful bile duct stone clearance (feasibility)	Patient not showing any signs of choledocholithiasis (fever, pale stool, dark urine, right upper quadrant pain, elevated cholestasis parameters) at 6 week follow up	At the 6 week follow up appointment
Secondary	Number of patients with injury to common bile duct	Injury to common bile duct is defined as contrast agent leakage from common bile duct during cholangiography or an obvious lesion.	During operation, up to 2 hours
Secondary	Intraoperative blood loss	Measured in ml	During operation, up to 2 hours
Secondary	Intraoperative blood substitution	Number of erythrocyte concentrates (275ml each)	During operation, up to 2 hours
Secondary	Number of patients with lesion to surrounding organs	stomach, duodenum, liver, small bowel, colon	During operation, up to 2 hours
Secondary	Number of patients with postoperative bile leak	Bile leakage is defined as bilirubin concentration in the drain fluid at least 3 times the serum bilirubin concentration on or after postoperative day 3 or as the need for radiologic or operative intervention resulting from biliary collections or biliary peritonitis	From operation up to 6 weeks postoperative
Secondary	Number of patients with postoperative significant bleeding	Significant bleeding is defined as a drop in haemoglobin level > 3 g/dl post-operatively compared with the post-operative baseline level and/or any post-operative transfusion of packed red blood cells for a falling haemoglobin and/or the need for radiological intervention (such as embolization) and/or re-operation to stop bleeding	From operation up to 6 weeks postoperative
Secondary	Number of patients with postoperative cholangitis	Cholangitis is defined according to the Tokyo Guidelines 2018 [17]: The guidelines encompass systemic TCPBD-Pilot-Tr ial Version 4.0 of 14.09.2020 Page 29 of 41 inflammation (fever, chills or increased inflammatory markers), cholestasis (jaundice or abnormal liver function tests) and imaging (biliary dilation or evidence of stricture, stone or stent). Diagnosis can be suspected in cases of systemic inflammation and one of the two other parameters. Diagnosis is confirmed if all three parameters are present.	From operation up to 6 weeks postoperative
Secondary	Number of patients with postoperative lipasaemia	Lipasaemia is defined as elevation in serum lipase to ten times or greater than the upper limit of normal. It is measured 4 hours after the intervention	4 hours after the operation
Secondary	Number of patients with postoperative acute pancreatitis	The diagnosis of acute pancreatitis is defined by the presence of two of the following three criteria: acute onset of persistent, severe, epigastric pain often radiating to the back, elevation in serum lipase or amylase to three times or greater than the upper limit of normal, and characteristic findings of acute pancreatitis on imaging (contrast-enhanced computed tomography, magnetic resonance imaging, or transabdominal ultrasonography)	From operation up to 6 weeks postoperative